5 key challenges facing 23andMe ahead of its public debut

Hello,

Welcome to Insider Healthcare. I'm Lydia Ramsey Pflanzer, and today in healthcare news:

If you're new to this newsletter, sign up here. Comments or tips? Email me at [email protected] or tweet @lydiaramsey125. Now, let's get to it...


Some breaking news for you this morning - Pfizer and BioNTech's COVID-19 vaccine was highly effective at preventing infections in kids ages 12 to 15, the company said Wednesday morning. That's according to results from a trial of more than 2,000 12- to 15-year-olds.

Find out more here>>


DNA Testing 23andMe

We just got the best look yet at the consumer genetics market ahead of 23andMe's public debut. Here are the 5 biggest obstacles the $3.6 billion company will have to overcome.

Get the full analysis here>>


World Health Organization (WHO) Director-General Tedros Adhanom Ghebreyesus attends a news conference organized by Geneva Association of United Nations Correspondents (ACANU) amid the COVID-19 outbreak, caused by the novel coronavirus, at the WHO headquarters in Geneva Switzerland July 3, 2020.
World Health Organization (WHO) Director-General Tedros Adhanom Ghebreyesus attends a news conference organized by Geneva Association of United Nations Correspondents (ACANU) amid the COVID-19 outbreak, caused by the novel coronavirus, at the WHO headquarters in Geneva Switzerland July 3, 2020.

The WHO's leader said its investigation into whether the coronavirus leaked from a Wuhan lab was not 'extensive enough'

Find out more here>>


Walmart Health
A Walmart Health clinic with counseling, labs, optometry, primary care, dental, and hearing services.

A top Walmart healthcare exec is leaving the retail giant

Read the full memo sent to staff here>>


More stories we're reading:


- Lydia

Read the original article on Business Insider

Comments are closed.